A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate

Lipsky PE. Rheumatoid arthritis. In: Fauci AS, Braunwald E, Isselbacher KJ, et al., eds. Harrison's principles of internal medicine. 14th ed. New York: McGraw-Hill, 1994:1880-8.

10.1056/NEJM198503283121303

10.1002/art.1780290702

10.1111/j.1365-2249.1991.tb05777.x

10.1084/jem.162.6.2163

10.1038/319516a0

10.1038/322547a0

von Asmuth EJU, 1991, J Immunol, 147, 3869, 10.4049/jimmunol.147.11.3869

10.1007/BF00920793

10.1016/S0140-6736(89)90430-3

10.1093/infdis/163.6.1267

10.1056/NEJM199707173370301

Moreland LW, 1998, J Investig Med, 46, 228A

10.1002/art.1780310302

10.1002/art.1780350502

10.1002/art.1780360601

Fries JF, 1982, J Rheumatol, 9, 789

10.1056/NEJM199507203330301

Guidance for industry: clinical development programs for drugs, devices, and biological products for the treatment of rheumatoid arthritis (RA): draft guidance. Washington, D.C.: Food and Drug Administration, March 1998. (Seehttp://www.fda.gov/cder/guidance/index.htm.) (Also available from NAPS [document no. 05498 for 52 pages], c/o Microfiche Publications, P.O. Box 3513, Grand Central Station, New York, NY 10163-3513.)

10.1056/NEJM199605163342002

Alarcón GS. Methotrexate: its use for the treatment of rheumatoid arthritis and other rheumatic disorders. In: Koopman WJ, ed. Arthritis and allied conditions: a textbook of rheumatology. 13th ed. Vol. 1. Baltimore: Williams & Wilkins, 1997:679-98.

Weinblatt ME. Methotrexate. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, eds. Textbook of rheumatology. 5th ed. Vol. 1. Philadelphia: W.B. Saunders, 1997:771-86.

Moreland LW, 1998, J Investig Med, 46, 229A